Details for Patent: 9,032,965
✉ Email this page to a colleague
Which drugs does patent 9,032,965 protect, and when does it expire?
Patent 9,032,965 protects LUMISIGHT and is included in one NDA.
Summary for Patent: 9,032,965
| Title: | Methods and system for image guided cell ablation with microscopic resolution |
| Abstract: | The invention provides systems and method for the removal of diseased cells during surgery. |
| Inventor(s): | Lee W. David |
| Assignee: | Lumicell, Inc. |
| Application Number: | US14219074 |
|
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 9,032,965
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lumicell | LUMISIGHT | pegulicianine acetate | POWDER;INTRAVENOUS | 214511-001 | Apr 17, 2024 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | A METHOD COMPRISING ADMINISTERING PEGULICIANINE TO A HUMAN AND OBTAINING AN IMAGE OF A TUMOR BED AFTER TUMOR RESECTION TO DISTINGUISH IN SITU CANCER CELLS FROM HEALTHY CELLS | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
